Delivery Order SPE2DB22D3301-SPE2DB25FY9FS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This firm fixed-price contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $9,106.00 to AmerisourceBergen Drug Corp for the supply of RhoGAM Ultra-Filtered Plus syringes under contract 4569065080. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location in that same city. This delivery order is...
- This is a $2,360.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- This is a contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rhogam Ultra-Filtered Plus Syrs. The contract is a delivery order with a firm fixed price of $1,392.60 and an ultimate completion date of May 8, 2023. It is not associated with any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The delivery order has a ceiling value of $1,969.36 and is a firm fixed price contract. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,360.40 firm fixed-price contract is for the supply of Rhogam Ultra-Filtered Plus syringes, a critical medical product. The award is not set aside and has an ultimate completion date of November 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medications, vaccines, and medical supplies to support various government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price of $1,138.25 and a completion date of July 24, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9FSDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,969.36 delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under a larger indefinite delivery contract (IDC) vehicle, leveraging the company's pharmaceutical supply capabilities to support federal medical procurement requirements. This delivery order falls under AmerisourceBergen's significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill competitive federal procurement requirements and manage substantial pharmaceutical supply chains positions it as a critical vendor within the Department of Defense's medical logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/12/25 |